ArticleJournal of cancer research and clinical oncology2023

Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage.

Zhi-Bin Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.